AHR and neoplasm: Notably, they identified a modulator which induced AhR-dependent Fas ligand expression and breast and liver tumor cell apoptosis without increasing expression of the prototypical AhR target gene, CYP1A1, suggesting that AhR transcriptional activity can be fine-tuned, to specifically unlock its function as a tumor suppressor.